New drug combination gets approval in U S for cervical cancer
GlaxoSmithKline Plc drug Hycamtin and the chemotherapy agent cisplatin together may treat women with cervical cancer. Food and Drug Administration has approved this new drug combination in U S. It can be used when surgery and radiation does not have any..
New drug combination gets approval in U S for cervical cancer Read More »